Agentix (AGTX) Change in Cash (2013 - 2026)
Agentix's (AGTX) quarterly Change in Cash came in at -$5625.0 in Q1 2026, down 48.18% YoY from -$10855.4 in Q1 2025, and down 807.55% on a QoQ basis from $795.0 in Q4 2025.
Agentix (AGTX) Change in Cash (2013 - 2026) Analysis & Trends
Agentix (AGTX) has 14 years of Change in Cash data on file, last reported at -$5625.0 in Q1 2026.
- Quarterly Change in Cash fell 48.18% year-over-year to -$5625.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3706.0 (down 80.08% YoY) and the FY2026 annual result came in at -$3706.0, down 80.08% from the prior year.
- Change in Cash slipped to -$5625.0 in Q1 2026, from $795.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $21682.0 in Q3 2023 to a low of -$24058.0 in Q4 2023.
- A 5-year average of $39.12 and a median of $419.5 in 2022 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 762.79% in 2023, down 14902.27% in 2023.
- Tracing AGTX's Change in Cash over 5 years: stood at -$2023.0 in 2022, then plunged by 1089.22% to -$24058.0 in 2023, then jumped by 108.01% to $1928.0 in 2024, then tumbled by 58.77% to $795.0 in 2025, then slumped by 807.55% to -$5625.0 in 2026.
- The last three Change in Cash figures came in at -$5625.0 (Q1 2026), $795.0 (Q4 2025), and $1189.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | -733.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -733.00 |
| Mar 31, 2026 | -5,625.00 |
| Dec 31, 2025 | 795.00 |
| Sep 30, 2025 | 1,189.00 |
| Jun 30, 2025 | -65.00 |
| Mar 31, 2025 | -3,796.00 |
| Dec 31, 2024 | 1,928.00 |
| Sep 30, 2024 | -2,727.00 |
| Jun 30, 2024 | 2,537.00 |
| Mar 31, 2024 | 3,055.00 |
| Dec 31, 2023 | -24,058.00 |
| Sep 30, 2023 | 21,682.00 |
| Jun 30, 2023 | -6,513.00 |
| Mar 31, 2023 | 11,690.00 |
| Dec 31, 2022 | -2,023.00 |
| Sep 30, 2022 | 2,513.00 |
| Jun 30, 2022 | 44.00 |
| Nov 30, 2021 | -531.00 |
| Aug 31, 2021 | -6,040.00 |
| Feb 28, 2021 | -10,245.00 |